MedTrace Logo

Statin Interchange by Pharmacist Collaborative Practice Agreement (CPA)

NCT01222182 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 260

Last updated 2012-05-28

No results posted yet for this study

Summary

A group of \~ 225 patients were switched from atorvastatin to an equivalent statin either by their physicians usual management or by an collaborative pharmacist coordinated process. We will compare the results of pharmacist process to the standard medical practice to find potentially which process is more effective, safer and efficient. We are surveying a total of 35 physicians, 12 using the pharmacist coordinated process and 23 not, comparing their satisfaction of the 2 processes.

Conditions

Interventions

DRUG

atorvastatin

All patients desired to change atorvastatin 10, 20mg to an equivalent that is covered by their prescription plan. This is accomplished by either pharmacists by MD/Pharmacist practice agreement or physicians in usual practice

Sponsors & Collaborators

Principal Investigators

  • Laura Odell, PharmD, RPh · Mayo Clinic

Eligibility

Min Age
25 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-09-30
Primary Completion
2011-02-28
Completion
2011-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01222182 on ClinicalTrials.gov